Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransCode Therapeutics Inc.

11.50
+0.40003.60%
Post-market: 11.500.00000.00%19:57 EDT
Volume:36.63K
Turnover:414.09K
Market Cap:9.59M
PE:-0.02
High:12.22
Open:10.80
Low:10.17
Close:11.10
Loading ...

BRIEF-Transcode Therapeutics, Inc. Announces Closing Of Registered Direct Offering

Reuters
·
26 Mar

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live
·
25 Mar

Top Midday Decliners

MT Newswires Live
·
25 Mar

TransCode Therapeutics Starts $10 Million Direct Offering of Stock, Warrants

MT Newswires Live
·
24 Mar

TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PR Newswire
·
24 Mar

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Reuters
·
21 Mar

Wall Street Set to Open Lower Friday as Investors Look to End Losing Week Streak

MT Newswires Live
·
21 Mar

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers

MT Newswires Live
·
13 Mar

Transcode Therapeutics’ fourth cohort in Phase 1/2 cancer trial approved

TIPRANKS
·
13 Mar

TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial

PR Newswire
·
13 Mar

TransCode Therapeutics, Inc. Announces Results of Special Meeting

PR Newswire
·
26 Feb

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast

Benzinga
·
26 Feb

Transcode Therapeutics Inc trading resumes

TIPRANKS
·
22 Feb

Top Midday Gainers

MT Newswires Live
·
07 Feb

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Feb

Promising Clinical Developments Drive Buy Rating for TransCode Therapeutics

TIPRANKS
·
06 Feb

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial

PR Newswire
·
06 Feb

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
05 Feb

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting

PR Newswire
·
05 Feb